Tocotrienols (Vitamin E Family)

Evidence Level
Moderate
2 Clinical Trials
5 Documented Benefits
3/5 Evidence Score

Tocotrienols are the less common 4 of 8 vitamin E family members — distinct from the 4 tocopherols. Found primarily in palm oil, annatto, rice bran. Have unique double bonds in side chain that confer different biological activity than tocopherols — particularly stronger antioxidant effects, cholesterol-lowering, neuroprotection, and anti-cancer research. Annatto-derived delta + gamma tocotrienols are popular branded forms (DeltaGold®, EVNol SupraBio™).

Studied Dose 100-400 mg/day total tocotrienols; for cholesterol/CV: 200-300 mg gamma+delta tocotrienols; bone health: 100-200 mg/day
Active Compound Alpha-, Beta-, Gamma-, Delta-Tocotrienols (4 isomers; gamma + delta most studied)

Benefits

Cholesterol-Lowering Effects

Gamma- and delta-tocotrienols inhibit HMG-CoA reductase (the same enzyme statins target) — modestly reduce LDL cholesterol. Multiple trials with 100-200 mg/day showing 8-20% LDL reductions. Less potent than statins but mechanism is statin-like.

Antioxidant Activity (Distinct from Tocopherols)

Tocotrienols have unique unsaturated isoprenoid side chain — distribute more readily into cell membranes than tocopherols. Some research suggests 40-60× stronger antioxidant activity than alpha-tocopherol in certain assays.

Neuroprotection (Stroke Research)

Sen Sashwati et al. research at Ohio State showed nanomolar concentrations of alpha-tocotrienol protect neurons from glutamate-induced excitotoxicity (stroke model). NIH-funded research; clinical translation pending. Theoretical neuroprotective applications.

Bone Health (Animal Evidence)

Animal studies (especially Norazlina M and others in Malaysia) show tocotrienols may modestly support bone mineral density and reduce bone resorption markers. Human evidence limited; some trials in postmenopausal women showing modest benefit.

Non-Alcoholic Fatty Liver Disease (NAFLD)

Multiple trials (especially Magosso 2013, Pervez 2018) show tocotrienols modestly reduce hepatic steatosis, ALT, AST in NAFLD patients. Effect modest; lifestyle intervention foundational.

Mechanism of action

1

HMG-CoA Reductase Inhibition

Tocotrienols (especially gamma- and delta-) suppress HMG-CoA reductase via post-transcriptional regulation — reducing cholesterol synthesis. Mechanism distinct from but partially overlapping with statins.

2

Membrane Distribution

Unsaturated isoprenoid side chain allows tocotrienols to penetrate cell membranes more uniformly than tocopherols. May concentrate at membrane sites where lipid peroxidation occurs — explains potent antioxidant effects in some assays.

3

Anti-Inflammatory NF-κB Inhibition

Tocotrienols (especially gamma and delta) inhibit NF-κB signaling — reducing inflammatory cytokine production. Basis for anti-inflammatory and anti-cancer research.

4

Tocopherol Antagonism (Important Caution)

Alpha-tocopherol (the most common vitamin E form in supplements) interferes with tocotrienol absorption and biological activity. Tocotrienol products are typically alpha-tocopherol-free or low. Concurrent high-dose alpha-tocopherol supplementation NEGATES tocotrienol benefits.

Clinical trials

1
Tocotrienols for NAFLD

Clinical trial of mixed tocotrienols (200 mg BID) vs placebo in 87 NAFLD patients for 12 months. Outcomes: hepatic steatosis (ultrasound), liver enzymes, lipid panel.

87 NAFLD patients.

Tocotrienols significantly improved hepatic steatosis grade, reduced AST and ALT vs placebo. Modest LDL reduction. Lifestyle intervention remains foundational for NAFLD; tocotrienols adjunctive.

2
Tocotrienols for Cholesterol — Multiple Clinical Trial

Multiple clinical trials of tocotrienols (typically 100-200 mg/day) for hypercholesterolemia. Effect varies with formulation, baseline cholesterol, and concurrent alpha-tocopherol intake.

Hypercholesterolemic adults.

Tocotrienols (especially annatto-derived gamma + delta) modestly reduce LDL ~8-20%. Less potent than statins. Effect attenuated by concurrent alpha-tocopherol. Clinical relevance secondary to statins for high-risk patients.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated.
GI distress at high doses.
Bleeding risk at very high doses (vitamin E family inhibits platelet function).
Headache rare.
Fatigue rare.

Important Drug interactions

Anticoagulants (warfarin, apixaban, rivaroxaban) — vitamin E family inhibits platelet aggregation; theoretical bleeding risk; monitor.
Antiplatelet drugs (aspirin, clopidogrel) — additive bleeding risk.
Statins — theoretical additive cholesterol effect; mechanism partially overlapping (HMG-CoA reductase); generally compatible.
Cyclosporine — vitamin E may modestly increase levels.
Alpha-tocopherol supplementation — interferes with tocotrienol benefits; avoid concurrent high-dose mixed tocopherol supplements.
Cholesterol-lowering bile acid sequestrants — may reduce tocotrienol absorption.

Frequently asked questions about Tocotrienols (Vitamin E Family)

What are tocotrienols?

Tocotrienols are a less common subgroup of the vitamin E family (distinct from the more familiar tocopherols), found in palm, rice bran, and annatto. They are studied for cholesterol, liver, and cardiovascular support and for potent antioxidant activity.

How are tocotrienols different from tocopherols?

Both are forms of vitamin E, but tocotrienols have a slightly different structure that may give them stronger antioxidant action in cell membranes and some unique effects on cholesterol and the liver. Many tocotrienol products are tocopherol-free to avoid interference.

How much tocotrienols should I take?

Studies commonly use about 100 to 300 mg of tocotrienols per day, often from annatto or rice bran. Take them with food (with fat) for absorption, and split larger doses. Give cholesterol or other goals several weeks.

Are tocotrienols safe?

They are generally well tolerated. Like other vitamin E forms, they may have a mild blood-thinning effect at higher doses, so check with your doctor if you take anticoagulants or are having surgery.

What is Tocotrienols?

Tocotrienols are the less common 4 of 8 vitamin E family members — distinct from the 4 tocopherols. Found primarily in palm oil, annatto, rice bran. Have unique double bonds in side chain that confer different biological activity than tocopherols — particularly stronger antioxidant effects, cholesterol-lowering, neurop…

What is Tocotrienols used for?

Tocotrienols is researched primarily for Antioxidant, Cardiovascular, and Cognitive. Gamma- and delta-tocotrienols inhibit HMG-CoA reductase (the same enzyme statins target) — modestly reduce LDL cholesterol. Multiple trials with 100-200 mg/day showing 8-20% LDL reductions.

What is the recommended dosage of Tocotrienols?

The clinically studied dose is 100-400 mg/day total tocotrienols; for cholesterol/CV: 200-300 mg gamma+delta tocotrienols; bone health: 100-200 mg/day Always follow the product label and check with a healthcare provider for personal advice.

Is Tocotrienols safe, and does it have side effects?

For most healthy adults, Tocotrienols is well tolerated at studied doses. Reported effects can include: Generally well-tolerated. GI distress at high doses. It may also interact with some medications. Tocotrienols is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Tocotrienols interact with any medications?

Possible interactions include: Anticoagulants (warfarin, apixaban, rivaroxaban) — vitamin E family inhibits platelet aggregation; theoretical bleeding risk; monitor. Antiplatelet drugs (aspirin, clopidogrel) — additive bleeding risk. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Tocotrienols?

NutraSmarts rates the evidence for Tocotrienols as Moderate (3 out of 5). It is backed by 2 clinical trials and 1 cited reference summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(1 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Zuo S, Wang G, Han Q, et al. The effects of tocotrienol supplementation on lipid profile: A meta-analysis of randomized controlled trials. Complement Ther Med. 2020;52:102450..PubMedUsed to support: Meta-analysis supporting tocotrienols for improving lipid profile.